Towards personalizing treatment for depression: Developing treatment values markers

Patient

Volumn 6, Issue 1, 2013, Pages 35-43

  Wittink, Marsha N ^a   Morales, Knashawn H ^b   Cary, Mark ^b   Gallo, Joseph J ^c   Bartels, Stephen J ^d  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATTRIBUTABLE RISK; AVOIDANCE BEHAVIOR; CLINICAL ASSESSMENT; CLINICAL FEATURE; DEPRESSION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; GENERAL PRACTITIONER; HUMAN; INTERNET; LATENT STRUCTURE ANALYSIS; MAJOR CLINICAL STUDY; MENTAL HEALTH CARE PERSONNEL; OUTCOME ASSESSMENT; PATIENT COUNSELING; PERSONALIZED MEDICINE; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SPIRITUAL CARE;

ADULT; ANTIDEPRESSIVE AGENTS; COUNSELING; DEPRESSION; DIRECTIVE COUNSELING; HUMANS; INDIVIDUALIZED MEDICINE; PATIENT COMPLIANCE; PATIENT PREFERENCE; PATIENT SATISFACTION; PATIENT-CENTERED CARE; POPULATION SURVEILLANCE; QUESTIONNAIRES;

EID: 84874638814     PISSN: 11781653     EISSN: 11781661     Source Type: Journal    
DOI: 10.1007/s40271-013-0003-6     Document Type: Article

References (43)

1. de Leon J. AmpliChip CYP450 test: personalized medicine has arrived in psychiatry. Expert Rev Mol Diagn. 2006;6(3):277-86. (Pubitemid 44174334)
2. de Leon J. Pharmacogenomics: the promise of personalized medicine for CNS disorders. Neuropsychopharmacology. 2009;34(1):159-72.
3. Malhotra AK, Murphy GM, Kennedy JL. Pharmacogenetics of psychotropic drug response. Am J Psychiat. 2004;161(5):780-96. (Pubitemid 38625331)
4. Stewart M, Brown JB, Weston WW, et al. Patient-centered medicine. Thousand Oaks: Sage Publications; 1995.
5. Thompson J, Scott N. Counseling service features: elders' preferences and utilization. Clin Gerontol. 1991;11:39-46.
6. Bedi N, Chilvers C, Churchill R, et al. Assessing effectiveness of treatment of depression in primary care. Partially randomised preference trial. Br J Psychiatry. 2000;177:312-8.
7. Dwight-Johnson M, Unützer J, Sherbourne C, et al. Can quality improvement programs for depression in primary care address patient preferences for treatment? Med Care. 2001;39(9):934-44. (Pubitemid 33603651)
8. Bourgeron T, Giros B. Genetic markers in psychiatric genetics. Methods Mol Med. 2003;77:63-98.
9. Pence BW, O'Donnell JK, Gaynes BN. The depression treatment cascade in primary care: a public health perspective. Curr Psychiatry Rep. 2012;14(4):3228-35.
10. Zikmund-Fisher BJ, Couper MP, Singer E, et al. The DECISIONS Study: a nationwide survey of United States adults regarding 9 common medical decisions. Med Decis Making. 2010;30(5 Suppl):20S-34S.
11. Balkrishnan R, Rajagopalan R, Camacho FT, et al. Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study. Clin Ther. 2003;25(11):2958-71. (Pubitemid 37510603)
12. Irvine J, Baker B, Smith J, et al. Poor adherence to placebo or amiodarone therapy predicts mortality: results from the CAMIAT study. Psychosom Med. 1999;61(4):566-75. (Pubitemid 29360322)
13. Hope CJ, Wu JQ, Tu WZ, et al. Association of medication adherence, knowledge, and skills with emergency department visits by adults 50 years and older with congestive heart failure. Am J Health-Syst Ph. 2004;61(19):2043-9. (Pubitemid 39485217)
14. Dwight-Johnson M, Lagomasino IT, Aisenberg E, et al. Using conjoint analysis to assess depression treatment preferences among low-income Latinos. Psychiatr Serv. 2004;55(8):934-6. (Pubitemid 39025222)
15. Givens JL, Houston TK, Van Voorhees BW, et al. Ethnicity and preferences for depression treatment. Gen Hosp Psychiatry. 2007;29(3):182-91. (Pubitemid 46680533)
16. Edelen MO, Burnam MA, Watkins KE, et al. Obtaining utility estimates of the health value of commonly prescribed treatments for asthma and depression. Med Decis Mak. 2008;28(5):732-50.
17. Gum AM, Areán PA, Hunkeler E, et al. Depression treatment preferences in older primary care patients. Gerontologist. 2006;46(1):14-22. (Pubitemid 43214411)
18. Cooper LA, Gonzales JJ, Gallo JJ, et al. The acceptability of treatment for depression among African-American, Hispanic, and white primary care patients. Med Care. 2003;41(4):479-89.
19. Rokke P, Scogin F. Depression treatment preferences in younger and older adults. J Clin Geropsychol. 1995;1(3):243-57.
20. Unützer J, Katon W, Williams JW, et al. Improving primary care for depression in late life: the design of a multicenter randomized trial. Med Care. 2001;39(8):785-99. (Pubitemid 33686262)
21. Wittink MN, Joo JH, Lewis LM, et al. Losing faith and using faith: older African Americans discuss spirituality, religious activities, and depression. J Gen Intern Med. 2009;24(3):402-7.
22. Cooper LA, Brown C, Vu HT, et al. Primary care patients' opinions regarding the importance of various aspects of care for depression. Gen Hosp Psychiat. 2000;22(3):163-73. (Pubitemid 30394710)
23. Luce RD, Tukey JW. Simultaneous conjoint measurement: a new scale type of fundamental measurement. J Math Psychol. 1964;1(1):1-27.
24. Flach SD, Diener A. Eliciting patients' preferences for cigarette and alcohol cessation: an application of conjoint analysis. Addict Behav. 2004;29(4):791-9. (Pubitemid 38591587)
25. Wittink MN, Cary MS, TenHave T, et al. Towards patient-centered care for depression: conjoint methods to tailor treatment based on preferences. Patient. 2010;3(3):145-57.
26. Gurmankin AD, Baron J, Armstrong K. Intended message versus message received in hypothetical physician risk communications: exploring the gap. Risk Anal. 2004;5:1337-47. (Pubitemid 39532463)
27. Kuhfeld W. Marketing research methods for SAS: experimental design, choice, conjoint, and graphical techniques [SAS 9.1 Edition]. Cary: SAS Institute Inc.; 2005.
28. Shulberg HC, Kato W, Simon GE, et al. Treating major depression in primary care practice: an update of the Agency for Health Care Policy and Research Practice Guidelines. Arch Gen Psychiatry. 1998;55(12):1121-7. (Pubitemid 28558285)
29. Train K. Discrete choice methods with simulation. Cambridge: Cambridge University Press; 2003.
30. Marshall P, Bradlow ET. A unified approach to conjoint analysis models. J Am Stat Assoc. 2002;97(459):674-82.
31. Vermunt JK, Magidson J. Latent class cluster analysis. In: Hagenaars J, McCutcheon A, editors. Applied latent class analysis. Cambridge: Cambridge University Press; 2002. p. 89-106.
32. Kilbourne AM, Switzer G, Hyman K, et al. Advancing health disparities research within the health care system: a conceptual framework. Am J Public Health. 2006;96(12):2113-21. (Pubitemid 44865101)
33. Zullino D, Conus P, Borgeat F, Bonsack C. Readiness to participate in psychiatric research. Can J Psychiatry. 2003;48:480-4. (Pubitemid 37295208)
34. Woodall A, Morgan C, Sloan A, et al. Barriers to participation in mental health research: are there specific gender, ethnicity and age related barriers? BMC Psychiatry. 2010;10:103.
35. Wittink DR, Krishnamurthi L, Reibstein DJ. The effects of differences in the number of attribute levels on conjoint results. Mark Lett. 1989;1(6):113-23.
36. Singh J, Cuttler L, Shin M, et al. Medical decision-making and the patient: understanding preference patterns for growth hormone therapy using conjoint analysis. Med Care. 1998;36(8):AS31-45. (Pubitemid 128455030)
37. McLachlan GJ, Basford KE. Mixture Models: Inference and applications to clustering. New York: Marcel Dekker; 1988.
38. Gelhorn HL, Sexton CC, Classi PM. Patient preferences for treatment of major depressive disorder and the impact on health outcomes: a systematic review. Prim Care Companion CNS Disord. 2011;13(5):PCC:11r01161.
39. Vavra T, Green P, Krieger A. Evaluating EZ-Pass. Mark Res. 1999;11:5-16.
40. Wind J, Green P, Shifflet D, Scarbrough M. Courtyard by Marriott: designing a hotel facility with consumer-based marketing models. Interfaces. 1989;19:25-47.
41. Bridges J, Kinter E, Kidane L, et al. Things are looking up since we started listening to patients: trends in the application of conjoint analysis in health 1982-2007. Patient. 2008;4(1):273-82.
42. Marshal D, Bridges JF, Hauber B, Cameron R, et al. Conjoint analysis applications in health: how are studies being designed and reported? An update on current practice in the published literature between 2005 and 2008. Patient. 2010;3(40):249-56.
43. Wittink MN, Morales K, Cary M. Personalizing treatment for depression: developing values markers. In: Sawtooth Software, Inc. Sawtooth Software Conference Proceedings 2010. Orem: Sawtooth Software. Inc.; 2011, p. 181-92.